Trial intelligence / Profile preview

Amifostine for Oxaliplatin-Induced Neuropathy in Colorectal Cancer

NCT00601198Phase 2Terminated

Sponsor
University of Cincinnati
Start
Oct 2006
Primary completion
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of amifostine, sponsored by University of Cincinnati. Started Oct 2006; status: terminated.

02

Drugs

amifostine

Beyond the preview

Go deeper on NCT00601198.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00601198.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call